恆指挫逾500點失萬九關 匯控及藥明生物續跌逾半成 內需股捱沽
瑞銀於亞洲股市周一(20日)開市前宣布,同意以總代價30億瑞郎換股方式收購陷入財困的瑞信(CS.US),並同意承擔瑞信最多50億瑞郎的損失,瑞士央行則會向瑞銀及瑞信提供合共一千億瑞郎的流動性資金支援。美股期貨全面回升,惟高位遇壓,現僅回升約0.1%至0.3%。亞太區主要股市今早(20日)普遍受壓。
恆指繼上周五反彈1.6%後,今早重失百天線,更跌穿萬九關,現報18,990,現跌528點或2.7%,創約三個月低,總成交額603億元。此外,科指及國指各跌約2.7%及2.3%。
藍籌股普遍受壓,權重金融股匯控(00005.HK)續挫5.5%報50.85元,股價失守百天線(約51元),友邦(01299.HK)及中國平安(02318.HK)分別重失牛熊線(約78.5元)及百天線(約50.5元),最低見76.1元及49.85元,現報76.75元及50.15元,各回吐近3%。
藥明生物(02269.HK)曾低見44.6元,創逾三個月低,現報45.5元,續挫逾5%。績後獲高盛及里昂降價的李寧(02331.HK)未止跌,最低見53.6元,現報54.85元,續挫4.9%。內需股蒙牛(02319.HK)、安踏(02020.HK)及潤啤(00291.HK)亦各跌逾4%。
龍湖(00960.HK)、碧桂園(02007.HK)及碧服(06098.HK)、東方海外(00316.HK)及阿里健康(00241.HK)跌逾3%至4%。海底撈(06862.HK)回吐5.7%,曾低見19.56元(暫守穩百天線19.53元)。美團-W(03690.HK)重失10天線(129.2元),最低見126.4元,現報127.4元,回吐2.3%。
騰訊(00700.HK)、舜宇(02382.HK)及阿里-SW(09988.HK)吐逾1.5%至2%。然而,百度-SW(09888.HK)逆市續漲近3%,曾高見148元,百度旗下「文心一言」推出後獲客戶熱烈反應,並獲大行看好。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.